| Carter SF, Schöll M, Almkvist O, et al.
Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. [Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't]
J Nucl Med 2012 Jan; 53(1):37-46.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Xiao H, Lv F, Xu W, et al.
Deprenyl prevents MPP(+)-induced oxidative damage in PC12 cells by the upregulation of Nrf2-mediated NQO1 expression through the activation of PI3K/Akt and Erk. [Journal Article, Research Support, Non-U.S. Gov't]
Toxicology 2011 Dec 18; 290(2-3):286-94.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Brown JA, Xu J, Diggs-Andrews KA, et al.
PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.]
Exp Neurol 2011 Dec; 232(2):333-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Nag S, Lehmann L, Heinrich T, et al.
Synthesis of three novel fluorine-18 labeled analogues of L-deprenyl for positron emission tomography (PET) studies of monoamine oxidase B (MAO-B). [In Vitro, Journal Article, Research Support, Non-U.S. Gov't]
J Med Chem 2011 Oct 27; 54(20):7023-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bakhshalizadeh S, Esmaeili F, Houshmand F, et al.
Effects of selegiline, a monoamine oxidase B inhibitor, on differentiation of P19 embryonal carcinoma stem cells, into neuron-like cells. [Journal Article, Research Support, Non-U.S. Gov't]
In Vitro Cell Dev Biol Anim 2011 Sep; 47(8):550-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Santillo AF, Gambini JP, Lannfelt L, et al.
In vivo imaging of astrocytosis in Alzheimer's disease: an ¹¹C-L-deuteriodeprenyl and PIB PET study. [Journal Article]
Eur J Nucl Med Mol Imaging 2011 Dec; 38(12):2202-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Huang X, Auinger P, Eberly S, et al.
Serum cholesterol and the progression of Parkinson's disease: results from DATATOP. [Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't]
PLoS One 2011; 6(8):e22854.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | LeWitt P, Schultz L, Auinger P, et al.
CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Brain Res 2011 Aug 23.:88-97.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Matos MJ, Vazquez-Rodriguez S, Uriarte E, et al.
MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins. [Comparative Study, Journal Article, Research Support, Non-U.S. Gov't]
Bioorg Med Chem Lett 2011 Jul 15; 21(14):4224-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Chen CC, Fang CL, Al-Suwayeh SA, et al.
Transdermal delivery of selegiline from alginate-Pluronic composite thermogels. [In Vitro, Journal Article]
Int J Pharm 2011 Aug 30; 415(1-2):119-28.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
|
